Peer-reviewed paper in 2026 shows mycelial compounds effective against respiratory diseases?
One-OffGesundheit & MedizinWissenschaft2MonManifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseJa 81.4%
Prognostiker
12
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 1 Stunde
Verzogert12. Nov. 25, 04:56 UTC31. Dez. 26, 23:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Will a peer-reviewed paper analyzing UAP sensor data be published in a Nature-family journal before January 1, 2027?
Manifold MarketsDate first peer reviewed manuscript in Cell, Nature, or Science concludes SARS2 lab origin more likely than not (Set)
Manifold MarketsWill China unveil a peer reviewed surgical cure for Alzheimers by the end of 2026?
Manifold MarketsWill a graviton be directly observed in a peer-reviewed paper before 2100?
Manifold MarketsWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiWill the VLA15 Lyme Disease vaccine "pass" its phase 3 human trial?
Manifold MarketsRegeln
Particularly against severe / pandemic-risk disease such as CoV-2, H5N1, or so on.
- Resolves YES if one is published which shows statistically significant effects using mushroom or mycelium-derived extracts or compounds.
- Otherwise NO at end of 2026.
